Kedaara Capital had picked up a 40% stake in the diagnostic chain in 2016 for over Rs400 crore.
Vijaya Diagnostic is one of the largest integrated diagnostic chains in southern India. It offers a one-stop solution for pathology and radiology testing services through an extensive operational network, which consists of 80 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata. During the fiscal year 2021, the company derived 96.2% of its revenue from operations from its core geographies of Hyderabad and the rest of Telangana and Andhra Pradesh.
For the fiscal years 2021, 2020 and 2019, the diagnostic chain reported a revenue Rs3,88.5 crore, Rs3,54.1 crore and Rs3,02.9 crore, respectively and it reported a profit of Rs84.9 crore, Rs62.5 crore and Rs46.2 crore, respectively.
Stay home🏠, stay safe, wear a mask😷 and protect self and others around you.
Vijaya Diagnostic is one of the largest integrated diagnostic chains in southern India. It offers a one-stop solution for pathology and radiology testing services through an extensive operational network, which consists of 80 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata. During the fiscal year 2021, the company derived 96.2% of its revenue from operations from its core geographies of Hyderabad and the rest of Telangana and Andhra Pradesh.
For the fiscal years 2021, 2020 and 2019, the diagnostic chain reported a revenue Rs3,88.5 crore, Rs3,54.1 crore and Rs3,02.9 crore, respectively and it reported a profit of Rs84.9 crore, Rs62.5 crore and Rs46.2 crore, respectively.
Stay home🏠, stay safe, wear a mask😷 and protect self and others around you.
An OFS consist of upto 7 lakh shares by Parul Chetankumar Vaghasia, upto 1.5 million shares by Girishkumar Limbabhai Chovatia, up to 3.05 million shares by Kiranben Girishbhai Chovatia, upto 1.74 lakh shares by Aruna Jayantkumar Pandya.
For the fiscal year 2021, the company reported a revenue of ₹340.61 crore versus ₹239.64 crore a year ago. Net profit for the period stood at ₹53.99 crore against ₹27.47 crore last year.
Ami Organics is the leading research and development driven manufacturers of specialty chemicals with varied end usage, focused on the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients and New Chemical Entities and key starting material for agrochemical and fine chemicals, especially from our recent acquisition of the business of Gujarat Organics Ltd.
Stay home🏠, stay safe, wear a mask😷 and protect self and others around you.
For the fiscal year 2021, the company reported a revenue of ₹340.61 crore versus ₹239.64 crore a year ago. Net profit for the period stood at ₹53.99 crore against ₹27.47 crore last year.
Ami Organics is the leading research and development driven manufacturers of specialty chemicals with varied end usage, focused on the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients and New Chemical Entities and key starting material for agrochemical and fine chemicals, especially from our recent acquisition of the business of Gujarat Organics Ltd.
Stay home🏠, stay safe, wear a mask😷 and protect self and others around you.
With the bullish in the market, GMP of shyam metaliks has raised to 130 levels... Once we know the price band, GMP will move accordingly
Shyam metaliks will have a reservation portion for employees of 3,00,000 equity shares.
LIC IPO : Sources says LIC Ipo to hit Exchanges in Q4 of FY 22 , Expects LIC valuation to be completed by oct month
PM Modi to address nation today at 5 pm.
Be careful about your overnight positions, since the event is after market hours, any announcement from PM may effect your positions, PM is expected to make a comment on Economy and need for vaccine.
Be careful about your overnight positions, since the event is after market hours, any announcement from PM may effect your positions, PM is expected to make a comment on Economy and need for vaccine.
2 IPOs approved by SEBI:
1. Glenmark Life Sciences
2. Utkarsh Small Finance Bank
1. Glenmark Life Sciences
2. Utkarsh Small Finance Bank
Sona BLW IPO Dates Confirmed
Issue Opens : 14 June 2021
Issue Closes : 16 June 2021
Issue Size : ₹ 5,550 Crore (Est. Rs. 6,000 Cr)
Retail Quota : 10% of Issue Size
Issue Opens : 14 June 2021
Issue Closes : 16 June 2021
Issue Size : ₹ 5,550 Crore (Est. Rs. 6,000 Cr)
Retail Quota : 10% of Issue Size
Utkarsh Small finance Bank gets SEBI approval for Initial Public offering
*Sona BLW* Precision Forgings Details 👍
Issue Dates : *14-16 June*
Issue Size : ₹ 5,550 Crore
Price Band : ₹ 285-291
Bid Lot Size : *51 Shares*
Application Amount : *₹ 14,841*
Retail Quota : 10%
Registrar - Kfintech
Number of Retail Applications : 3,73,964 Approx
Issue Dates : *14-16 June*
Issue Size : ₹ 5,550 Crore
Price Band : ₹ 285-291
Bid Lot Size : *51 Shares*
Application Amount : *₹ 14,841*
Retail Quota : 10%
Registrar - Kfintech
Number of Retail Applications : 3,73,964 Approx